DE69615019T2 - Benzopyrane und diese enthaltende pharmazeutische zusammenstellungen - Google Patents
Benzopyrane und diese enthaltende pharmazeutische zusammenstellungenInfo
- Publication number
- DE69615019T2 DE69615019T2 DE69615019T DE69615019T DE69615019T2 DE 69615019 T2 DE69615019 T2 DE 69615019T2 DE 69615019 T DE69615019 T DE 69615019T DE 69615019 T DE69615019 T DE 69615019T DE 69615019 T2 DE69615019 T2 DE 69615019T2
- Authority
- DE
- Germany
- Prior art keywords
- benzopyran
- dihydro
- dimethyl
- hydroxy
- trans
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyrane Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9510477.4A GB9510477D0 (en) | 1995-05-24 | 1995-05-24 | Organic compounds |
| PCT/EP1996/002257 WO1996037490A1 (en) | 1995-05-24 | 1996-05-24 | Benzopyrans and pharmaceutical compositions containing them |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69615019D1 DE69615019D1 (de) | 2001-10-11 |
| DE69615019T2 true DE69615019T2 (de) | 2002-06-06 |
Family
ID=10774940
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69615019T Expired - Lifetime DE69615019T2 (de) | 1995-05-24 | 1996-05-24 | Benzopyrane und diese enthaltende pharmazeutische zusammenstellungen |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US5905156A (enExample) |
| EP (1) | EP0828733B1 (enExample) |
| JP (1) | JPH11505820A (enExample) |
| KR (1) | KR100437981B1 (enExample) |
| CN (1) | CN1077888C (enExample) |
| AR (1) | AR004489A1 (enExample) |
| AT (1) | ATE205204T1 (enExample) |
| AU (1) | AU703276B2 (enExample) |
| BR (1) | BR9609048A (enExample) |
| CA (1) | CA2217821C (enExample) |
| CO (1) | CO4700520A1 (enExample) |
| CZ (1) | CZ294474B6 (enExample) |
| DE (1) | DE69615019T2 (enExample) |
| DK (1) | DK0828733T3 (enExample) |
| ES (1) | ES2163634T3 (enExample) |
| FI (1) | FI973992L (enExample) |
| GB (1) | GB9510477D0 (enExample) |
| HU (1) | HU222772B1 (enExample) |
| IL (1) | IL118382A (enExample) |
| MY (1) | MY114924A (enExample) |
| NO (1) | NO314846B1 (enExample) |
| NZ (1) | NZ309765A (enExample) |
| PL (1) | PL184144B1 (enExample) |
| PT (1) | PT828733E (enExample) |
| RU (1) | RU2160735C2 (enExample) |
| SK (1) | SK283215B6 (enExample) |
| TR (1) | TR199701417T1 (enExample) |
| TW (1) | TW421646B (enExample) |
| WO (1) | WO1996037490A1 (enExample) |
| ZA (1) | ZA964209B (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5972894A (en) * | 1997-08-07 | 1999-10-26 | Cytran, Inc. | Peptides having potassium channel opener activity |
| GB9822024D0 (en) * | 1998-10-09 | 1998-12-02 | Novartis Ag | Organic compounds |
| GB9909792D0 (en) | 1998-12-04 | 1999-06-23 | Cambridge Bioclinical Limited | Potassium channel activators and their use |
| US6384244B2 (en) | 2000-05-18 | 2002-05-07 | Merck & Co., Inc. | Process for preparing cis- aminochromanols |
| ZA200501510B (en) * | 2002-08-29 | 2006-10-25 | Nissan Chemical Ind Ltd | Process for producing aminobenzopyran compound |
| US7098340B2 (en) * | 2003-05-14 | 2006-08-29 | Warner Lambert Company Llc | Benzyl sulfonamide derivatives |
| KR100704009B1 (ko) * | 2005-08-30 | 2007-04-04 | 한국화학연구원 | 염증억제 활성을 가지는6-알킬아미노-2-메틸-2'-(ｎ-메틸치환술폰아미도)메틸-2ｈ-1-벤조피란 유도체 |
| BR112018006189A2 (pt) | 2015-09-28 | 2018-10-09 | Genentech Inc | compostos da fórmula, composição farmacêutica, métodos de tratamento de uma doença, de diminuição do fluxo de íons e de tratamento de prurido em um mamífero, método para tratamento de dores em um mamífero e uso de um composto |
| CN106008288A (zh) * | 2016-06-15 | 2016-10-12 | 西北农林科技大学 | 一种苯磺酰胺类化合物及其用途 |
| JP2020511511A (ja) * | 2017-03-24 | 2020-04-16 | ジェネンテック， インコーポレイテッド | ナトリウムチャネル阻害剤としての４−ピペリジン−ｎ−（ピリミジン−４−イル）クロマン−７−スルホンアミド誘導体 |
| TW202003490A (zh) | 2018-05-22 | 2020-01-16 | 瑞士商赫孚孟拉羅股份公司 | 治療性化合物及其使用方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4971982A (en) * | 1987-07-06 | 1990-11-20 | Hoffmann-La Roche Inc. | Benzopyran derivatives |
| ES2030627A6 (es) * | 1990-11-28 | 1992-11-01 | Uriach & Cia Sa J | Procedimiento para la obtencion de compuestos benzopiranicos. |
| GB9102803D0 (en) * | 1991-02-11 | 1991-03-27 | Ici Plc | Pyridine compounds |
| KR950009863B1 (ko) * | 1991-05-22 | 1995-08-29 | 재단법인한국화학연구소 | 벤조피란 유도체와 그의 제조방법 |
| TW244350B (enExample) * | 1991-12-14 | 1995-04-01 | Hoechst Ag | |
| US5236935A (en) * | 1992-05-21 | 1993-08-17 | Korea Research Institute Of Chemical Technology | Benzopyran derivatives and processes for the preparation thereof |
-
1995
- 1995-05-24 GB GBGB9510477.4A patent/GB9510477D0/en active Pending
-
1996
- 1996-05-22 TW TW085106034A patent/TW421646B/zh not_active IP Right Cessation
- 1996-05-22 MY MYPI96001911A patent/MY114924A/en unknown
- 1996-05-22 IL IL11838296A patent/IL118382A/xx not_active IP Right Cessation
- 1996-05-23 CO CO96026387A patent/CO4700520A1/es unknown
- 1996-05-24 ES ES96917431T patent/ES2163634T3/es not_active Expired - Lifetime
- 1996-05-24 PL PL96324042A patent/PL184144B1/pl not_active IP Right Cessation
- 1996-05-24 CA CA002217821A patent/CA2217821C/en not_active Expired - Fee Related
- 1996-05-24 BR BR9609048A patent/BR9609048A/pt not_active IP Right Cessation
- 1996-05-24 FI FI973992A patent/FI973992L/fi unknown
- 1996-05-24 US US08/952,549 patent/US5905156A/en not_active Expired - Lifetime
- 1996-05-24 PT PT96917431T patent/PT828733E/pt unknown
- 1996-05-24 WO PCT/EP1996/002257 patent/WO1996037490A1/en not_active Ceased
- 1996-05-24 AR ARP960102708A patent/AR004489A1/es active IP Right Grant
- 1996-05-24 EP EP96917431A patent/EP0828733B1/en not_active Expired - Lifetime
- 1996-05-24 AU AU60008/96A patent/AU703276B2/en not_active Ceased
- 1996-05-24 CN CN96194146A patent/CN1077888C/zh not_active Expired - Fee Related
- 1996-05-24 RU RU97120993/04A patent/RU2160735C2/ru not_active IP Right Cessation
- 1996-05-24 NZ NZ309765A patent/NZ309765A/xx unknown
- 1996-05-24 JP JP8535402A patent/JPH11505820A/ja not_active Ceased
- 1996-05-24 AT AT96917431T patent/ATE205204T1/de active
- 1996-05-24 TR TR97/01417T patent/TR199701417T1/xx unknown
- 1996-05-24 DE DE69615019T patent/DE69615019T2/de not_active Expired - Lifetime
- 1996-05-24 HU HU9801751A patent/HU222772B1/hu not_active IP Right Cessation
- 1996-05-24 ZA ZA9604209A patent/ZA964209B/xx unknown
- 1996-05-24 SK SK1577-97A patent/SK283215B6/sk not_active IP Right Cessation
- 1996-05-24 CZ CZ19973688A patent/CZ294474B6/cs not_active IP Right Cessation
- 1996-05-24 KR KR1019970708400A patent/KR100437981B1/ko not_active Expired - Fee Related
- 1996-05-24 DK DK96917431T patent/DK0828733T3/da active
-
1997
- 1997-11-21 NO NO19975365A patent/NO314846B1/no unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69123124T2 (de) | Dihydro-Isoquinolinderivate | |
| DE69031649T2 (de) | Oxoindolderivate | |
| DE69631784T2 (de) | 3-(4-subst.-piperidinyl-1)-1-(3,4-dichlorophenyl)propylcarbamate und -harnstoffe und andere derivative als neue neurokinin-antagonisten | |
| DE68926729T2 (de) | Benzopyranderivate mit einer blutdrucksenkenden Wirkung | |
| DD300434A5 (de) | Heterozyklische derivate | |
| DE69318238T2 (de) | Benzopyran-Verbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung als Zellenschutzmittel | |
| DE69015322T2 (de) | Substituierte Zyklobutendion-Verbindungen. | |
| DE69615019T2 (de) | Benzopyrane und diese enthaltende pharmazeutische zusammenstellungen | |
| DE69613457T2 (de) | 5-(4-subst.-piperidinyl-1)-3-aryl-pentansäure derivate als tachykinin rezeptor antagonisten | |
| DE60206376T2 (de) | Faktor xa inhibitor | |
| EP0351720B1 (de) | Verwendung substituierter 3,4-Dihydro-2H-benzopyrane als Heilmittel gegen obstruktive Funktionsstörungen der Lunge | |
| WO1994012493A1 (en) | 2,2-dialkyl- and 2,2-dialkyl-3,4-dihydro-3-hydroxy-2h-1-benzopyr ans, their use as pharmaceuticals | |
| DE69128845T2 (de) | 4-[3-(4-Oxothiazoldinyl)]butynylamine, Verfahren zu deren Herstellung und ihre Verwendung als Medikament | |
| DE2819215C2 (enExample) | ||
| DE69602248T4 (de) | 4a-aryldecahydroisochinolin-verbindungen und ihre medizinische verwendungen | |
| DE10051320A1 (de) | Neue Neurokininantagonisten, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen | |
| AU665040B2 (en) | 4-carboxamido-6(pyridin-4-yl substituted benzopyran derivatives | |
| RU2104277C1 (ru) | 2-2-диалкил- или транс-2,2-диалкил-3,4-дигидро-3-гидрокси-6-(пиридин-4-ил)-2н-1-бензопиран | |
| DE10051321A1 (de) | Neue Neurokininantagonisten, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen | |
| NZ245321A (en) | Substituted 6-(pyridin-4-yl)-2h-1-benzopyran derivatives and pharmaceutical compositions thereof | |
| MXPA97009004A (en) | Benzopira | |
| EP0318851A2 (de) | Neue Labdanderivate, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | |
| CZ282091B6 (cs) | 2,2-Dialkyl-2H-1-benzopyrany a 2,2-dialkyl-3,4-dihydro-3-hydroxy-2H-1-benzopyrany |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8328 | Change in the person/name/address of the agent |
Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336 |
|
| 8328 | Change in the person/name/address of the agent |
Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN |